FIELD: medicine.
SUBSTANCE: samples are taken weekly within a territory of interest; the number of patients (N) is determined; the samples are analysed to determine the concentration of viral antigen RNA (Csample) and an infectious titre (ITsample) of the viral material, and an average rate
EFFECT: higher reliability of assessing the epidemic situation caused by viral infections.
8 cl, 11 dwg, 4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PREVENTIVE DRUG FOR INFLUENZA AND ACUTE RESPIRATORY VIRAL INFECTION | 2009 |
|
RU2401117C1 |
A DEVICE FOR CHANGING THE PROPERTIES OF PROTON-CONTAINING OBJECTS, CAPABLE OF IMPLEMENTING BIOPHYSICAL TECHNOLOGY FOR PREVENTING INFECTIOUS EPIDEMICS | 2020 |
|
RU2742762C1 |
INFLUENZA B VIRUS STRAIN 151/91 FOR MAKING DIAGNOSTICS | 1992 |
|
RU2031118C1 |
METHOD FOR PREVENTIVE TREATMENT OF CORONAVIRUS INFECTION | 2020 |
|
RU2777462C2 |
VACCINE COMPOSITION FOR USE IN IMMUNO-COMPROMISED POPULATIONS | 2013 |
|
RU2661408C2 |
METHOD FOR DIAGNOSING EPIDEMIC PAROTITIS | 2022 |
|
RU2785486C1 |
SPRAY FOR EMERGENCY PREVENTION OF ACUTE RESPIRATORY VIRAL INFECTIONS | 2017 |
|
RU2665959C1 |
VACCINE COMPOSITION FOR NON-IMMUNISED INDIVIDUALS | 2013 |
|
RU2661407C2 |
METHOD OF EVOLUTIONARY MODELING OF EPIDEMIC DYNAMICS OF HIV INFECTION | 2017 |
|
RU2677002C1 |
STRAIN OF INFLUENZA VIRUS A (H@/N@) FOR DIAGNOSTIC PREPARATIONS PRODUCING | 0 |
|
SU1789561A1 |
Authors
Dates
2015-12-27—Published
2014-03-31—Filed